ArticleComputers & electrical engineering : an international journal2022
A novel deep fusion strategy for COVID-19 prediction using multimodality approach.
Article in Computers & electrical engineering : an international journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ensemble multimodal deep learning for early diagnosis and accurate classification of COVID-19.Computers & electrical engineering : an international journal · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the last two years, the novel coronavirus has become a significant threat to the health of the public, and numerous approaches are developed to determine the symptoms of COVID-19. To deal with the complex symptoms of COVID-19, a Deep Learning-assisted Multi-modal Data Analysis (DMDA) approach is introduced to determine COVID-19 symptoms by utilizing acoustic and image-based data. Furthermore, the classified events are forwarded to the proposed Dynamic Fusion Strategy (DFS) for confirming the health status of the individual. Initially, the performance of the proposed solution is evaluated on both acoustic and image-based samples and the proposed solution attains the maximum accuracy of 96.88% and 98.76%, respectively. Similarly, the DFS has achieved an overall symptom determination accuracy of 98.72% which is highly acceptable for decision-making. Moreover, the proposed solution shows high reliability with an accuracy of 95.64% even in absence of any one of the data modalities during testing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.